Accelerate Diagnostics' Revenues Plunge | GenomeWeb

NEW YORK (GenomeWeb News) – Accelerate Diagnostics, formerly called Accelr8 Technology, today said that for the five months ended Dec. 31, 2012, its revenues dropped sharply on the loss of technical development fees.

The firm's Fiscal Year 2013 began on Aug. 1, 2012. In November the firm said that it would change its fiscal year to end on Dec. 31.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.